Development and validation of a sample stabilization strategy and a UPLC-MS/MS method for the simultaneous quantitation of acetylcholine (ACh), histamine (HA), and its metabolites in rat cerebrospinal fluid (CSF)

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 22, 2011, Pages 2023-2033

  Zhang, Yanhua ^a   Tingley, F David ^a   Tseng, Elaine ^a   Tella, Max ^a   Yang, Xin ^a   Groeber, Elizabeth ^a   Liu, Jianhua ^a   Li, Wenlin ^a   Schmidt, Christopher J ^a   Steenwyk, Rick ^a  

^a PFIZER INC   (United States)

Author keywords

Acetylcholine; Biological stability; Biomarker; Donepezil; Histamine; Prucalopride; Rat cerebrospinal fluid; Tele Methylhistamine; Tele Methylimidazolacetic acid; UPLC MS MS

Indexed keywords

ACETYLCHOLINE; BIOLOGICAL STABILITY; DONEPEZIL; HISTAMINE; PRUCALOPRIDE; TELE-METHYLHISTAMINE; TELE-METHYLIMIDAZOLACETIC ACID; UPLC-MS/MS;

BIOMARKERS; BODY FLUIDS; BRAIN; COLUMN CHROMATOGRAPHY; CONTROL SYSTEM SYNTHESIS; FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; STABILIZATION;

RATS;

ACETIC ACID DERIVATIVE; ACETYLCHOLINE; DONEPEZIL; DRUG METABOLITE; HISTAMINE; PHYSOSTIGMINE; PRUCALOPRIDE; TELE METHYLHISTAMINE; TELE METHYLIMIDAZOLACETIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; HALF LIFE TIME; HYDROPHILIC INTERACTION CHROMATOGRAPHY; IN VITRO STUDY; LIMIT OF QUANTITATION; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY; STANDARD; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ACETYLCHOLINE; ANIMALS; BENZOFURANS; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HISTAMINE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMIDAZOLES; INDANS; MALE; METHYLHISTAMINES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

RATTUS;

EID: 79959900247     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.05.030     Document Type: Article

References (43)

1. Sagales T., Domino E.F. Psychopharmacologia 1973, 29:307.
2. Wessler I., Kirkpatrick C.J., Racke K. Pharmacol. Ther. 1998, 77:59.
3. van der Zee E.A., Luiten P.G. Prog. Neurobiol. 1999, 58:409.
4. Ikarashi Y., Harigaya Y., Tomidokoro Y., Kanai M., Ikeda M., Matsubara E., Kawarabayashi T., Kuribara H., Younkin S.G., Maruyama Y., Shoji M. Neurobiol. Aging 2004, 25:483.
5. Tohgi H., Abe T., Hashiguchi K., Saheki M., Takahashi S. Neurosci. Lett. 1994, 177:139.
6. Ito C. Drug News Perspect. 2004, 17:383.
7. Prell G.D., Green J.P. Agents Actions 1994, 41:C5.
8. Prell G.D., Green J.P. Agents Actions 1991, (Suppl. 33):343.
9. Soya A., Song Y.H., Kodama T., Honda Y., Fujiki N., Nishino S. Neurosci. Lett. 2008, 430:224.
10. Fernandez-Novoa L., Corzo L., Zas R., Alvarez X.A., Cacabelos R. Ann. N.Y. Acad. Sci. 1997, 826:396.
11. Bacciottini L., Passani M.B., Mannaioni P.F., Blandina P. Behav. Brain Res. 2001, 124:183.
12. Mochizuki T., Okakura-Mochizuki K., Horii A., Yamamoto Y., Yamatodani A. J. Neurochem. 1994, 62:2275.
13. Bacciottini L., Passani M.B., Giovannelli L., Cangioli I., Mannaioni P.F., Schunack W., Blandina P. Eur. J. Neurosci. 2002, 15:1669.
14. Stavinoha W.B., Weintraub S.T. Anal. Chem. 1974, 46:757.
15. Huang T., Yang L., Gitzen J., Kissinger P.T., Vreeke M., Heller A. J. Chromatogr. B: Biomed. Appl. 1995, 670:323.
16. Zhang M.Y., Hughes Z.A., Kerns E.H., Lin Q., Beyer C.E. J. Pharm. Biomed. Anal. 2007, 44:586.
17. Zhang M.Y., Beyer C.E. J. Pharm. Biomed. Anal. 2006, 40:492.
18. Prokai L., Frycak P., Stevens S.M., Nguyen V. Chromatographia 2008, 68:s101.
19. Shackman H.M., Shou M., Cellar N.A., Watson C.J., Kennedy R.T. J. Neurosci. Methods 2007, 159:86.
20. Uutela P., Reinila R., Piepponen P., Ketola R.A., Kostiainen R. Rapid Commun. Mass Spectrom. 2005, 19:2950.
21. Keski-Rahkonen P., Lehtonen M., Ihalainen J., Sarajarvi T., Auriola S. Rapid Commun. Mass Spectrom. 2007, 21:2933.
22. Zhu Y., Wong P.S., Cregor M., Gitzen J.F., Coury L.A., Kissinger P.T. Rapid Commun. Mass Spectrom. 2000, 14:1695.
23. Prell G.D., Green J.P., Kaufmann C.A., Khandelwal J.K., Morrishow A.M., Kirch D.G., Linnoila M., Wyatt R.J. Schizophr. Res. 1995, 14:93.
24. Carrozzo M.M., Cannazza G., Pinetti D., Di Viesti V., Battisti U., Braghiroli D., Parenti C., Baraldi M. J. Neurosci. Methods 2010, 194:87.
25. Prell G.D., Morrishow A.M., Duoyon E., Lee W.S. J. Neurochem. 1997, 68:142.
26. Nirogi R., Kandikere V., Mudigonda K., Bhyrapuneni G., Muddana N., Saralaya R., Benade V. J. Neurosci. Methods 2009, 178:116.
27. Nirogi R., Mudigonda K., Kandikere V., Ponnamaneni R. Biomed. Chromatogr. 2010, 24:39.
28. Zhang Y., Dufield D., Klover J., Li W., Szekely-Klepser G., Lepsy C., Sadagopan N. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2009, 877:513.
29. Reubsaet J.L., Ahlsen E., Haneborg K.G., Ringvold A. J. Chromatogr. Sci. 2003, 41:151.
30. Lacroix L.P., Ceolin L., Zocchi A., Varnier G., Garzotti M., Curcuruto O., Heidbreder C.A. J. Neurosci. Methods 2006, 157:25.
31. Hows M.E., Organ A.J., Murray S., Dawson L.A., Foxton R., Heidbreder C., Hughes Z.A., Lacroix L., Shah A.J. J. Neurosci. Methods 2002, 121:33.
32. Stokvis E., Rosing H., Beijnen J.H. Rapid Commun. Mass Spectrom. 2005, 19:401.
33. Li W., Cohen L.H. Anal. Chem. 2003, 75:5854.
34. Jemal M., Schuster A., Whigan D.B. Rapid Commun. Mass Spectrom. 2003, 17:1723.
35. Schulze F., Wesemann R., Schwedhelm E., Sydow K., Albsmeier J., Cooke J.P., Boger R.H. Clin. Chem. Lab. Med. 2004, 42:1377.
36. Ben Menachem E., Persson L., Schechter P.J., Haegele K.D., Huebert N., Hardenberg J. J. Neurochem. 1989, 52:632.
37. Lanckmans K., Sarre S., Smolders I., Michotte Y. Talanta 2008, 74:458.
38. Y. Zhang, H. Wang, E. Zegarac, R. Durham, C. Lepsy, in: 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Washington, DC, 2009, p. 39.
39. Stein H.H., Lewis G.J. Biochem. Pharmacol. 1969, 18:1679.
40. Lee J.W., Devanarayan V., Barrett Y.C., Weiner R., Allinson J., Fountain S., Keller S., Weinryb I., Green M., Duan L., Rogers J.A., Millham R., O'Brien P.J., Sailstad J., Khan M., Ray C., Wagner J.A. Pharm. Res. 2006, 23:312.
41. A. Ogden, R. Kozak, X. Ren, Y. Zhang, E. Tseng, E. Miller, A. Sawant, in: 10th Alzheimer's Association International Conference on Alzheimer's Disease 2010, Honolulu, Hawaii, 2010.
42. Consolo S., Arnaboldi S., Giorgi S., Russi G., Ladinsky H. Neuroreport 1994, 5:1230.
43. Mohler E.G., Shacham S., Noiman S., Lezoualc'h F., Robert S., Gastineau M., Rutkowski J., Marantz Y., Dumuis A., Bockaert J., Gold P.E., Ragozzino M.E. Neuropharmacology 2007, 53:563.